Concentrations etoposide drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Cell Line, Tumor Tumor Cells, Cultured HL-60 Cells T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes Cell Line Dendritic Cells Killer Cells, Natural Lymphocytes, Tumor-Infiltrating T-Lymphocytes

Organisms7

Mice, Nude Mice, Inbred BALB C Mice, Inbred C57BL Mice, SCID Adenoviridae Oncolytic Viruses Mice, Inbred DBA

Diseases41

Carcinoma, Small Cell Leukemia P388 Lung Neoplasms Neoplasms, Experimental Neoplasms Sarcoma 180 Melanoma, Experimental Leukemia L1210 Germinoma Leukopenia Testicular Neoplasms Hodgkin Disease Neoplasms, Germ Cell and Embryonal Lymphoma, Non-Hodgkin Hematologic Diseases Neutropenia Thrombocytopenia Colonic Neoplasms Melanoma Carcinoma, Lewis Lung Fibrosarcoma Neuroblastoma Lymphoma Sarcoma, Experimental Ovarian Neoplasms Brain Neoplasms Leukemia Carcinoma, Ehrlich Tumor Alopecia Retroperitoneal Neoplasms Adenocarcinoma Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Breast Neoplasms Bone Marrow Diseases Sarcoma, Ewing Neovascularization, Pathologic Neoplasm Recurrence, Local Recurrence Mammary Neoplasms, Experimental

Chemicals and Drugs61

Etoposide Antineoplastic Agents, Phytogenic Antineoplastic Agents Topoisomerase II Inhibitors Cisplatin Ifosfamide Doxorubicin DNA Topoisomerases, Type II Podophyllotoxin Antibiotics, Antineoplastic Cyclophosphamide Vincristine Amsacrine Carboplatin Bleomycin Cytarabine Teniposide Camptothecin Cancer Vaccines Topoisomerase I Inhibitors Antigens, Neoplasm Topoisomerase Inhibitors Mitoxantrone Paclitaxel Nucleic Acid Synthesis Inhibitors Topotecan Carmustine Razoxane Enediynes Prodrugs Vinblastine Organophosphorus Compounds Antineoplastic Agents, Alkylating P-Glycoprotein Antibodies, Monoclonal Melphalan Ellipticines Daunorubicin Enzyme Inhibitors Prednisone Caspases DNA Topoisomerases, Type I Procarbazine Methotrexate Granulocyte Colony-Stimulating Factor Proto-Oncogene Proteins c-bcl-2 Angiogenesis Inhibitors Caspase 3 Recombinant Proteins Tumor Suppressor Protein p53 Mesna DNA Neoplasm Proteins Levoleucovorin Aminoacridines Aclarubicin Intercalating Agents Immunotoxins Fluorouracil Acridines Mitomycin

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Combined Modality Therapy Neoplasms, Experimental Neoplasm Transplantation Melanoma, Experimental Administration, Oral Treatment Outcome Infusions, Intravenous Immunotherapy Transplantation, Autologous Remission Induction Drug Evaluation Survival Analysis Immunotherapy, Adoptive Survival Rate Transplantation, Heterologous Inhibitory Concentration 50 Disease-Free Survival Salvage Therapy Flow Cytometry Genetic Therapy Injections, Intralesional Oncolytic Virotherapy Sarcoma, Experimental Hematopoietic Stem Cell Transplantation Tumor Burden Transfection Blotting, Western Tumor Stem Cell Assay Maximum Tolerated Dose Bone Marrow Transplantation Drug Evaluation, Preclinical Mammary Neoplasms, Experimental

Phenomena and Processes25

Apoptosis Drug Synergism Dose-Response Relationship, Drug Drug Resistance, Neoplasm Cell Survival DNA Damage Cell Proliferation Drug Resistance Inhibitory Concentration 50 Drug Resistance, Multiple Cell Cycle Cell Division Time Factors Cytotoxicity, Immunologic Genetic Vectors Molecular Structure Transfection Maximum Tolerated Dose Cell Death Gene Expression Regulation, Neoplastic Half-Life Signal Transduction Drug Interactions Structure-Activity Relationship DNA Fragmentation

Information Science1

Health Care4

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Etoposide Antineoplastic Agents, Phytogenic Drug Screening Assays, Antitumor Antineoplastic Agents Xenograft Model Antitumor Assays Antineoplastic Combined Chemotherapy Protocols Topoisomerase II Inhibitors Cisplatin Ifosfamide Doxorubicin Carcinoma, Small Cell Cell Line, Tumor DNA Topoisomerases, Type II Podophyllotoxin Antibiotics, Antineoplastic Cyclophosphamide Vincristine Leukemia P388 Lung Neoplasms Tumor Cells, Cultured Amsacrine Drug Administration Schedule Mice, Nude Apoptosis Carboplatin Combined Modality Therapy Neoplasms, Experimental Neoplasm Transplantation Bleomycin Neoplasms Sarcoma 180 Melanoma, Experimental Drug Synergism Dose-Response Relationship, Drug Drug Resistance, Neoplasm Cytarabine Teniposide Camptothecin Cell Survival Mice, Inbred BALB C Leukemia L1210 Germinoma Cancer Vaccines Topoisomerase I Inhibitors Antigens, Neoplasm Administration, Oral Treatment Outcome Leukopenia Topoisomerase Inhibitors Mitoxantrone Paclitaxel Infusions, Intravenous Immunotherapy Nucleic Acid Synthesis Inhibitors DNA Damage Topotecan Transplantation, Autologous Remission Induction Mice, Inbred C57BL Cell Proliferation Drug Evaluation Carmustine Testicular Neoplasms Survival Analysis Hodgkin Disease Drug Resistance Mice, SCID Immunotherapy, Adoptive Neoplasms, Germ Cell and Embryonal Survival Rate Transplantation, Heterologous Razoxane Inhibitory Concentration 50 Lymphoma, Non-Hodgkin Disease-Free Survival Hematologic Diseases Enediynes Salvage Therapy Prodrugs Drug Resistance, Multiple Vinblastine Neutropenia Organophosphorus Compounds Antineoplastic Agents, Alkylating P-Glycoprotein Antibodies, Monoclonal Melphalan Cell Cycle Thrombocytopenia Ellipticines Daunorubicin HL-60 Cells Cell Division Colonic Neoplasms Melanoma Time Factors Flow Cytometry Carcinoma, Lewis Lung Genetic Therapy Enzyme Inhibitors

No FAQ available that match "concentrations etoposide drug screening assays antitumor"